PANCREATIC CANCER METASTATIC
Clinical trials for PANCREATIC CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cocktail takes on tough pancreatic cancer
Disease control TerminatedThis early-phase trial is testing whether adding two immunotherapy drugs (botensilimab and balstilimab) to a strong chemotherapy mix plus two oral medications (chloroquine and celecoxib) can help people with metastatic pancreatic cancer that hasn't been treated yet. The study inv…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New cancer drug BBI-355 trial halted early – what we know
Disease control TerminatedThis early-phase trial tested a new oral drug called BBI-355, alone or with other targeted therapies, in people with advanced solid tumors that had extra DNA (oncogene amplifications). The study aimed to find the safest dose and check for side effects. It was terminated early, so…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC